Elara 900 – Part 2: Comfort in Practice
August 5, 2026
Part 2 of a three-part series on Elara 900 explores how ergonomic design is reshaping the slit lamp experience for clinicians and patients alike
5 min read
False
Advertisement
July
Elara 900 – Part 2: Comfort in Practice
August 5, 2026
Part 2 of a three-part series on Elara 900 explores how ergonomic design is reshaping the slit lamp experience for clinicians and patients alike
5 min read
A Bone Drug for Glaucoma?
July 31, 2026
Study questions whether a pre-existing osteoporosis drug could reduce glaucoma and ocular hypertension risk
2 min read
Partnership Targets Intraocular Biologics
July 31, 2026
BioMed X and Boehringer launch new eye therapy research team
2 min read
EYP-1901 for Retinal Exudative Diseases: Multi-Mechanism of Action and Phase 2 Clinical Trial Highlights
July 30, 2026
An overview of nonclinical data supporting vorolanib’s multi-mechanism of action (MOA) and key findings from the phase 2 DAVIO 2 and VERONA clinical trials, presented at the 44th Annual American Society of Retina Specialists Meeting (July 15–18, 2026; Montréal, Canada).
6 min read
NIH Grant Backs Rare Eye Research
July 29, 2026
Georgia State and Columbia University researchers win $6.5m NIH grant to advance treatment for rare inherited eye disease
2 min read
Retinal Detachment: Timing the Outcome
July 29, 2026
Timing is everything in retinal detachment repair, new study reports
2 min read
The Hormone Link in Keratoconus
July 28, 2026
Recently published paper examines estrogen’s role in keratoconus
2 min read
Who Owns the Outcome?
July 27, 2026
Investigating the accountability gap in private ophthalmology
11 min read
Balance Ophthalmics Appoints New CCO
July 27, 2026
Balance Ophthalmics names Norbert Lowe as chief commercial officer ahead of launch of new glaucoma device
2 min read
Browse by Subspecialties
False
Advertisement